Insights

Rapid Investment Growth Xontogeny has demonstrated a strong investment track record, funding multiple early-stage biotech companies with large Series A rounds, indicating active capital deployment and a focus on innovative life sciences technologies. Engagement with their portfolio companies offers opportunities to provide complementary services or technology solutions that support early drug development stages.

Biotech Focused Network With a specialized focus on biotech startups developing therapies and advanced technologies for serious diseases, Xontogeny’s portfolio includes companies working on cataract surgery, white matter injury, protein design, and gene therapies. This presents potential for sales of biotech research tools, clinical trial support services, or specialized manufacturing solutions tailored to their portfolio companies.

Support for Entrepreneurial Innovation Xontogeny partners with entrepreneurs to support efficient development pathways and retain founder control, making them an ideal gateway to early-stage biotech companies and scientific founders. Building relationships here can open doors to pitching innovative products or services that streamline research, reduce costs, or accelerate development timelines.

Recent Funding Activities The company’s recent investments into diverse biotech sectors indicate an ongoing pipeline of promising startups, providing ample opportunities to offer early-stage R&D collaborations, licensing arrangements, or technology solutions that align with their investment interests in disruptive therapies and technologies.

Operational Tech Stack Xontogeny’s use of advanced digital tools like cloud services, website management, and security platforms suggests they value technological efficiency. Sales prospects include enterprise software, cloud-based research platforms, or cybersecurity solutions that can support their operational activities and enhance portfolio management.

Xontogeny Tech Stack

Xontogeny uses 8 technology products and services including WP Rocket, Cloudflare, Drupal, and more. Explore Xontogeny's tech stack below.

  • WP Rocket
    Caching
  • Cloudflare
    Content Management System
  • Drupal
    Content Management System
  • Microsoft 365
    Email
  • Google Fonts API
    Font Scripts
  • Kinsta
    Platform As A Service
  • Cloudflare Bot Management
    Security
  • Elementor Header & Footer Builder
    Web Platform Extensions

Media & News

Xontogeny's Email Address Formats

Xontogeny uses at least 1 format(s):
Xontogeny Email FormatsExamplePercentage
First@xontogeny.comJohn@xontogeny.com
36%
First_Last@xontogeny.comJohn_Doe@xontogeny.com
33%
LastFi@xontogeny.comDoeJo@xontogeny.com
17%
FirLast@xontogeny.comJohDoe@xontogeny.com
14%

Frequently Asked Questions

Where is Xontogeny's headquarters located?

Minus sign iconPlus sign icon
Xontogeny's main headquarters is located at 240 Newbury Street, 2nd Floor Boston, MA 02116, US. The company has employees across 2 continents, including North AmericaEurope.

What is Xontogeny's official website and social media links?

Minus sign iconPlus sign icon
Xontogeny's official website is xontogeny.com and has social profiles on LinkedInCrunchbase.

What is Xontogeny's SIC code NAICS code?

Minus sign iconPlus sign icon
Xontogeny's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Xontogeny have currently?

Minus sign iconPlus sign icon
As of October 2025, Xontogeny has approximately 9 employees across 2 continents, including North AmericaEurope. Key team members include Vice President Portfolio Operations: I. T.Vice President, Program Development: H. A. P.Manager, Executive Operations: M. C. C.. Explore Xontogeny's employee directory with LeadIQ.

What industry does Xontogeny belong to?

Minus sign iconPlus sign icon
Xontogeny operates in the Biotechnology Research industry.

What technology does Xontogeny use?

Minus sign iconPlus sign icon
Xontogeny's tech stack includes WP RocketCloudflareDrupalMicrosoft 365Google Fonts APIKinstaCloudflare Bot ManagementElementor Header & Footer Builder.

What is Xontogeny's email format?

Minus sign iconPlus sign icon
Xontogeny's email format typically follows the pattern of First@xontogeny.com. Find more Xontogeny email formats with LeadIQ.

How much funding has Xontogeny raised to date?

Minus sign iconPlus sign icon
As of October 2025, Xontogeny has raised $15M in funding. The last funding round occurred on May 18, 2017 for $15M.

When was Xontogeny founded?

Minus sign iconPlus sign icon
Xontogeny was founded in 2016.

Xontogeny

Biotechnology ResearchUnited States2-10 Employees

Xontogeny (zon-TOJ-uh-nee) is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients with serious diseases. Specifically, we partner with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development.

At Xontogeny, we believe that scientific founders supply the passion and determination integral to the success of their companies. While the foundation of success is good science, how that science is developed from inception to maturity serves as the critical pathway. Therefore, we focus on supporting the entrepreneur’s pursuit and optimizing the development pathway with an exceptionally talented and experienced operational team. With our team’s track record of success, entrepreneurs of affiliated companies will gain the support and guidance they need while remaining lean, virtual, and without the financial burden of supporting a full-time team.

This dynamic model has the additional benefit of supporting the goals of the founding scientists and entrepreneurs to retain more control and equity, while increasing the chance of accessing investment, and ultimately development success.

Section iconCompany Overview

Headquarters
240 Newbury Street, 2nd Floor Boston, MA 02116, US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
2-10

Section iconFunding & Financials

  • $15M

    Xontogeny has raised a total of $15M of funding over 1 rounds. Their latest funding round was raised on May 18, 2017 in the amount of $15M.

  • $1M$10M

    Xontogeny's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $15M

    Xontogeny has raised a total of $15M of funding over 1 rounds. Their latest funding round was raised on May 18, 2017 in the amount of $15M.

  • $1M$10M

    Xontogeny's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.